BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11866949)

  • 1. [Myoid/myofibroblastic differentiation in dermatofibrosarcoma protuberans: a clinicopathologic study of six cases].
    Wang J; Zhu X; Yosuke M; Masanori H; Hiroshi H
    Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):12-5. PubMed ID: 11866949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatofibrosarcoma protuberans and its fibrosarcomatous variant with areas of myoid differentiation: a report of three cases.
    Morimitsu Y; Hisaoka M; Okamoto S; Hashimoto H; Ushijima M
    Histopathology; 1998 Jun; 32(6):547-51. PubMed ID: 9675594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosarcomatous dermatofibrosarcoma protuberans with myofibroblastic differentiaion: a histologically distinctive variant [corrected].
    O'Connell JX; Trotter MJ
    Mod Pathol; 1996 Mar; 9(3):273-8. PubMed ID: 8685227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoid differentiation and EMA expression in fibrosarcomatous dermatofibrosarcoma protuberans.
    Arican O; Bakaris S; Bulbuloglu E; Ezberci F
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Mar; 15(1):39-44. PubMed ID: 16850098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: clinicopathologic analysis of 5 cases.
    Calonje E; Fletcher CD
    J Cutan Pathol; 1996 Feb; 23(1):30-6. PubMed ID: 8720984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
    Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
    Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans.
    Goldblum JR
    Arch Pathol Lab Med; 1995 Mar; 119(3):238-41. PubMed ID: 7534057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leiomyomatous nodules and bundles of vascular origin in the fibrosarcomatous variant of dermatofibrosarcoma protuberans.
    Sanz-Trelles A; Ayala-Carbonero A; Rodrigo-Fernández I; Weil-Lara B
    J Cutan Pathol; 1998 Jan; 25(1):44-9. PubMed ID: 9508343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
    Mentzel T; Schärer L; Kazakov DV; Michal M
    Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: 10 years' experience in a tertiary hospital.
    Lo CH; Tsang PM; Cheng SY
    Autops Case Rep; 2022; 12():e2021368. PubMed ID: 35496732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acral dermatofibrosarcoma protuberans with myoid differentiation: A report of 2 cases.
    Al-Zaid T; Khoja H
    J Cutan Pathol; 2017 Sep; 44(9):794-797. PubMed ID: 28627712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrosarcomatous dermatofibrosarcoma protuberans with giant rosettes.
    Zamecnik M
    Am J Dermatopathol; 2001 Feb; 23(1):41-5. PubMed ID: 11176051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Histological Subtypes of Dermatofibrosarcoma Protuberans Occurring in the Same Tumor.
    Socoliuc C; Zurac S; Andrei R; Stăniceanu F
    Rom J Intern Med; 2015; 53(1):79-88. PubMed ID: 26076565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.
    Reimann JD; Fletcher CD
    Am J Surg Pathol; 2007 Sep; 31(9):1371-7. PubMed ID: 17721193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrosarcomatous dermatofibrosarcoma protuberans: a clinicopathological analysis of 12 cases].
    Zhang J; Wu N; Xia C; Wei X; Shi QL; Zhou XJ; Ma J
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):753-7. PubMed ID: 24447553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of PDGFRβ-Akt-mTOR pathway signaling in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Hiraki-Hotokebuchi Y; Yamada Y; Kohashi K; Yamamoto H; Endo M; Setsu N; Yuki K; Ito T; Iwamoto Y; Furue M; Oda Y
    Hum Pathol; 2017 Sep; 67():60-68. PubMed ID: 28711648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatofibrosarcoma Protuberans of the Vulva With Myoid Differentiation.
    Bernárdez C; Machan S; Molina-Ruiz AM; Pérez de la Fuente T; Pavón M; Carrillo I; Fortes J; Requena L
    Am J Dermatopathol; 2015 Sep; 37(9):e107-11. PubMed ID: 25943241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
    Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinicopathologic review of a case series of dermatofibrosarcoma protuberans with fibrosarcomatous differentiation.
    Kuzel P; Mahmood MN; Metelitsa AI; Salopek TG
    J Cutan Med Surg; 2015; 19(1):28-34. PubMed ID: 25775660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans.
    Abbott JJ; Oliveira AM; Nascimento AG
    Am J Surg Pathol; 2006 Apr; 30(4):436-43. PubMed ID: 16625088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.